The Masonic Cancer Center, University of Minnesota, is the Twin Cities’ only Comprehensive Cancer Center, designated ‘Outstanding’ by the National Cancer Institute. As Minnesota’s Cancer Center, we have served the entire state for more than 30 years.
The Masonic Cancer Center at the University of Minnesota was established in 1991, and is part of a larger health care and education facility that includes the Medical School, College of Pharmacy, School of Public Health and more. The Masonic Cancer Center is one of 70 NCI-designated Comprehensi...
There are unique issues associated with both approaches. This chapter focuses on the 36,000 ft2 purpose-built stand-alone facility model in place at the University of Minnesota. This facility currently manufactures a wide range of cellular products that support 80 clinical studies....
Dr. John Marini is a professor of medicine at the University of Minnesota. He trained at Johns Hopkins University School of Medicine as well as the University of Washington in Seattle. He is the author and editor of numerous articles and textbooks and has published more than 400 scientific and...
who along with Norman Shumway pioneered total body hypothermia foropen heart surgerywhile at the University of Minnesota.24The livers were cooled by the intravascular infusion of chilledlactated Ringer solution(Fig. 1-5) and monitoring core temperature with thermal probes. This now-univers...
Assignee: Regents of the University of Minnesota (Minneapolis, MN) Primary Class: 424/85.1 Other Classes: 424/93.7, 424/277.1, 514/17.7, 514/19.3 International Classes: A61K38/00; A61K38/19; A61K39/00; A61P35/00; (IPC1-7): A61K38/19; A61K35/12; A61K38/00 Field of Search: ...
Lizbeth H. Finestack, PhD, CCC-SLP • University of Minnesota - Twin Cities PrevNext 1234 Current Happenings Grammatical Language Intervention Study We are looking for children with language weakness or impairment between the ages of 5 and 9 years to participate in a treatment research study foc...
Examples of such adjuvants include monophosphoryl lipid A (MPL), a detoxified derivative of the lipopolysaccharide (LPS) moiety of Salmonella Minnesota R595, which has retained immunostimulatory activities and has been shown to promote Th1 responses when co-administered with antigens (see U.S. Pat...
MRG/University of Minnesota (Minneapolis, MINNESOTA, US) Claims: 1.A method of treating a subject having or at risk of having a tumor, the method comprising:administering to the subject an amount of a PKC-NFκB axis inhibitor effective to ameliorate at least one symptom or clinical sign of...
VIKSNINS HARRIS PADYS MALEN LLP (Bloomington, MINNESOTA, US) Parent Case Data: RELATED APPLICATION This patent document claims the benefit of priority of U.S. application Ser. No. 60/711,563, filed Aug. 26, 2005, which application is herein incorporated by reference.Claims...